Introducing the Patient Safety Professional: Why, What, Who, How, and Where?

被引:12
|
作者
Saint, Sanjay [1 ,2 ]
Krein, Sarah L. [1 ,2 ,3 ]
Manojlovich, Milisa [3 ]
Kowalski, Christine P. [1 ]
Zawol, Debbie [1 ]
Shojania, Kaveh G. [4 ,5 ]
机构
[1] VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA
[3] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA
[4] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada
[5] Univ Toronto, Ctr Patient Safety, Toronto, ON, Canada
关键词
patient safety professional; safety; hospital; acquired complications; patient-centered care; prevention; noscomial infection; PHYSICIANS; CATHETER; QUALITY; RISK;
D O I
10.1097/PTS.0b013e318230e585
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Hospital-acquired complications, such as nosocomial infection, falls, and venous thromboembolism, are well known to be frequent and morbid. Unfortunately, prevention remains challenging. Two widely touted prevention strategies-checklists and reminders-have inherent barriers that limit their use as general solutions to these endemic problems. Likewise, relying upon additional vigilance and efforts of those already caring for patients may guarantee that hospital-acquired complications persist, given the time pressures already constraining bedside clinicians. Consequently, we recommend a new type of clinical role in the hospital setting, the "Patient Safety Professional'' (PSP), be considered to ensure that each patient receives individualized prevention strategies to minimize the hazards of hospitalization. The Role of the PSP: We envision the PSP would be an APRN who would assess assigned patients for hospital-acquired complications following explicit protocols relevant to a short list of safety targets; prioritize identified complications based on morbidity, mortality, and hospital costs; and develop and implement plans to decrease hospital-acquired complications, in consultation with physicians and staff nurses on the unit. We have recently hired such an individual at our hospital and describe-through several vignettes-what our PSP does on a daily basis. Evaluation of the PSP: The rollout, benefits, and costs of PSPs should be carefully evaluated before widespread dissemination is considered. Process measures and clinical outcomes should be monitored. Physician, nurse, and patient satisfaction also need to be assessed. Conclusions: Far from replacing the duties of frontline physicians and nurses assigned to care for the patient, we believe that a PSP will strengthen the safety net for hospitalized patients and serve as an expert resource.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [31] Shared responsibility: the who, what and how
    Lukasiewicz, Anna
    Dovers, Stephen
    Eburn, Michael
    ENVIRONMENTAL HAZARDS-HUMAN AND POLICY DIMENSIONS, 2017, 16 (04): : 291 - 313
  • [32] Value Lies in the Eye of the Patients: The Why, What, and How of Patient-reported Outcomes Measures
    Ciani, Oriana
    Federici, Carlo Baldassarre
    CLINICAL THERAPEUTICS, 2020, 42 (01) : 25 - 33
  • [33] Patient Safety and Error Management What Causes Adverse Events and How Can They Be Prevented?
    Hoffmann, Barbara
    Rohe, Julia
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2010, 107 (06): : 92 - U19
  • [34] Dashboards as a Service Why, What, How, and What Research Is Needed?
    Pauwels, Koen
    Ambler, Tim
    Clark, Bruce H.
    LaPointe, Pat
    Reibstein, David
    Skiera, Bernd
    Wierenga, Berend
    Wiesel, Thorsten
    JOURNAL OF SERVICE RESEARCH, 2009, 12 (02) : 175 - 189
  • [35] Low-dose aspirin in pregnancy: who? when? how much? and why?
    Mather, Andrew R.
    Dom, Aaron M.
    Thorburg, Loralei L.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (02) : 65 - 71
  • [36] Implementation of Medical Emergency Teams to Improve Perioperative Patient Safety. Who? When? How?
    Schewe, Jens-Christian
    Lenkeit, Stefan
    Ganser, Janina
    Heller, Axel R.
    Koch, Thea
    ZENTRALBLATT FUR CHIRURGIE, 2020, 145 (05): : 426 - 431
  • [37] Breast cancer risk reduction: who, why, and what?
    Bozzuto, Laura M.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2022, 83 : 36 - 45
  • [38] Neutropenia and antibiotics: when, what, how and why?
    Dickter, Jana
    Logan, Cathy
    Taplitz, Randy
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (04) : 218 - 227
  • [39] Neurosymbolic Artificial Intelligence (Why, What, and How)
    Sheth, Amit
    Roy, Kaushik
    Gaur, Manas
    IEEE INTELLIGENT SYSTEMS, 2023, 38 (03) : 56 - 62
  • [40] 'Insight' in medical training: what, why, and how?
    Ng, Isaac K. S.
    Lin, Norman H. Y.
    Goh, Wilson G. W.
    Teo, Desmond B.
    Tan, Li Feng
    Ban, Kenneth H. K.
    POSTGRADUATE MEDICAL JOURNAL, 2023, : 196 - 202